Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442-1451.
Chronic Kidney Disease Prognosis Consortium None., (2018), Kidney international, 94, 1025 - 1026
Erratum: Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR.(Kidney International Reports (2018) 3(3) (625–637)(S246802491830007X)(10.1016/j.ekir.2018.01.002))
Astor B. et al, (2018), Kidney International Reports, 3
Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium.
Inker LA. et al, (2018), American journal of kidney diseases : the official journal of the National Kidney Foundation
Hallifax RJ. et al, (2018), JAMA, 320, 1471 - 1480
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients with Chronic Kidney Disease: A Randomised Double-Blind Trial.
Haynes R. et al, (2018), Circulation
Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial.
(2018), American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 18, 1424 - 1434
Herrington WG. et al, (2018), Clinical trials (London, England), 15, 313 - 315
Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis.
Marthi A. et al, (2018), Journal of the American Society of Nephrology : JASN
Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.
Storey BC. et al, (2018), Kidney international, 93, 1165 - 1174
Storey BC. et al, (2018), Kidney international, 93, 1000 - 1007
Hicks KA. et al, (2018), Journal of the American College of Cardiology, 71, 1021 - 1034
A decade of the Clinical Trials Transformation Initiative: What have we accomplished? What have we learned?
Tenaerts P. et al, (2018), Clinical trials (London, England), 15, 5 - 12
Parish S. et al, (2018), Circulation. Genomic and precision medicine, 11
Hicks KA. et al, (2018), Circulation, 137, 961 - 972
Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection.
Mafham MM. et al, (2018), Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 33, 257 - 264
Use of Mobile Devices to Measure Outcomes in Clinical Research, 2010-2016: A Systematic Literature Review.
Perry B. et al, (2018), Digit Biomark, 2, 11 - 30
Effects of Anacetrapib on the Incidence of New-Onset Diabetes Mellitus and on Vascular Events in People With Diabetes
Bowman L. et al, (2017), CIRCULATION, 136, E451 - E451
Schlackow I. et al, (2017), Heart (British Cardiac Society), 103, 1880 - 1890
Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III-rationale, trial design and baseline data.
(2017), Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 32, 2043 - 2051